Skip to content

Sridhar Venkatesh's lobbying: the registrations they file and every meeting they've reported since November 2021.

← Lobbying

Registrant (responsible officer)

Sridhar Venkatesh

General Manager and President

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament
45
Since Nov 2021
145
Active registrations
0

Registered for

No registration in effect right now.

Earlier, since November 2021

Reported meetings

  • GlaxoSmithKline Inc.
    • Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
    Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Read more

    Official report

  • GlaxoSmithKline Inc.
    • Jean-Yves Duclos · Member of Parliament
    • Marjorie Michel · Minister of Health, Health Canada (HC)
    • Nancy Hamzawi · President, Public Health Agency of Canada (PHAC)
    • Justine Frame · Policy Advisor, Health Canada (HC)
    Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians. Read more

    Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada.

    National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada.

    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada

    Official report

  • GlaxoSmithKline Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
    Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians. Read more

    Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework.

    Official report

  • GlaxoSmithKline Inc.
    • Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
    • Arlette Kasongo · Director, Innovation, Science and Economic Development Canada (ISED)
    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Read more

    Official report

  • GlaxoSmithKline Inc.
    • Justine Frame · Policy Advisor, Health Canada (HC)
    National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Read more

    Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians.

    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada

    Official report

  • GlaxoSmithKline Inc.
    • Kabisan Thanendran · Policy Advisor, Public Services and Procurement Canada (PSPC)
    • chanel sterie · Director of Policy, Public Services and Procurement Canada (PSPC)
    Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework. Read more

    Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians.

    Official report

  • GlaxoSmithKline Inc.
    • Jacqueline Kosche · Directrice, Programmes de Contre-Mesure Médicale de Routine et Renforcement de la Chaîne Dâ??approvisionnement, Public Health Agency of Canada (PHAC)
    • sylvia haertel · Acting Supervisor,Senior Program Officer, Public Health Agency of Canada (PHAC)
    National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Read more

    Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians.

    Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada.

    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada

    Official report

  • GlaxoSmithKline Inc.
    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    • Justine Frame · Policy Advisor, Health Canada (HC)
    Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians. Read more

    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada

    National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
    Engagement with federal officials regarding Health Emergency Readiness Canada. Read more

    Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance)

    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding.

    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada

    Trade-related matters, including policies and tariffs impacting medicines and vaccines.

    Official report

  • GlaxoSmithKline Inc.
    • mohamed djeffal · Gestionnaire, Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
    • Arlette Kasongo · Gestionnaire, Innovation, Science and Economic Development Canada (ISED)
    Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Read more

    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding.

    Official report

  • GlaxoSmithKline Inc.
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    • mohamed djeffal · Manager, Innovation, Science and Economic Development Canada (ISED)
    Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Read more

    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding.

    Official report

  • GlaxoSmithKline Inc.
    • Jean-Yves Duclos · Député
    • maya ben kaled · Gestionaire de bureau, House of Commons
    • Anie-eve corbin · Adjointe de circonscription, House of Commons
    • Nelson Nzohabonimana · Adjoint de circonscription, House of Commons
    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada Read more

    Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework.

    Trade-related matters, including policies and tariffs impacting medicines and vaccines.

    Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians.

    Official report

  • GlaxoSmithKline Inc.
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Read more

    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding.

    Official report

  • GlaxoSmithKline Inc.
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Read more

    Official report

  • GlaxoSmithKline Inc.
    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Read more

    Official report

  • GlaxoSmithKline Inc.
    • Justine Frame · Policy Advisor, Health Canada (HC)
    National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Read more

    Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Read more

    Official report

  • GlaxoSmithKline Inc.
    • Ritu Banerjee · Sous-ministre adjoint(e), Innovation, Science and Economic Development Canada (ISED)
    • Fern Bannatyne · Directeur par intérim, Public Health Agency of Canada (PHAC)
    • paul place · Conseiller(ère) en politiques, Innovation, Science and Economic Development Canada (ISED)
    • Heather Deehan · Directrice, Public Health Agency of Canada (PHAC)
    and 1 more
    • Jacqueline Kosche · Directrice, Programmes de Contre-Mesure Médicale de Routine et Renforcement de la Chaîne Dâ??approvisionnement, Public Health Agency of Canada (PHAC)
    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Read more

    Official report

  • GlaxoSmithKline Inc.
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Read more

    Official report

  • GlaxoSmithKline Inc.
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Read more

    Official report

  • GlaxoSmithKline Inc.
    • Justine Frame · Advisor, Health Canada (HC)
    National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Read more

    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding.

    Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada.

    Official report

  • GlaxoSmithKline Inc.
    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada Read more

    Engagement with the Government regarding the Strategic Innovation Fund

    Official report

  • GlaxoSmithKline Inc.
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada. Read more

    Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians.

    Engagement with federal officials regarding Health Emergency Readiness Canada.

    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR.

    Engagement with the Government regarding the Strategic Innovation Fund

    Official report

  • GlaxoSmithKline Inc.
    • Salma Zahid · Member of Parliament
    • Jade Mallette · Chief of Staff to the Minister, Health Canada (HC)
    Policies and programs related to the health of new immigrants to Canada. Read more

    Policies, programs, and funding related to Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030.

    Official report

  • GlaxoSmithKline Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada Read more

    Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians.

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.